• News
    • Latest news
    • News search
    • Health
    • Finance
    • Food
    • Career news
    • Content series
    • Try Devex Pro
  • Jobs
    • Job search
    • Post a job
    • Employer search
    • CV Writing
    • Upcoming career events
    • Try Career Account
  • Funding
    • Funding search
    • Funding news
  • Talent
    • Candidate search
    • Devex Talent Solutions
  • Events
    • Upcoming and past events
    • Partner on an event
  • Post a job
  • About
      • About us
      • Membership
      • Newsletters
      • Advertising partnerships
      • Devex Talent Solutions
      • Contact us
Join DevexSign in
Join DevexSign in

News

  • Latest news
  • News search
  • Health
  • Finance
  • Food
  • Career news
  • Content series
  • Try Devex Pro

Jobs

  • Job search
  • Post a job
  • Employer search
  • CV Writing
  • Upcoming career events
  • Try Career Account

Funding

  • Funding search
  • Funding news

Talent

  • Candidate search
  • Devex Talent Solutions

Events

  • Upcoming and past events
  • Partner on an event
Post a job

About

  • About us
  • Membership
  • Newsletters
  • Advertising partnerships
  • Devex Talent Solutions
  • Contact us
  • My Devex
  • Update my profile % complete
  • Account & privacy settings
  • My saved jobs
  • Manage newsletters
  • Support
  • Sign out
Latest newsNews searchHealthFinanceFoodCareer newsContent seriesTry Devex Pro
    • News
    • Devex CheckUp

    Devex Checkup: ‘Turbocharged’ cholera wreaking havoc in a warming world

    In this week's edition: Cholera cases increase in a changing climate, Dakar ramps up its vaccine manufacturing, and a pandemic fund comes up severely short on cash.

    By Sara Jerving, Amruta Byatnal // 27 October 2022

    Presented by Pathfinder International

    Subscribe to Devex CheckUp today.

    After years of decline, cholera is on the rise — and experts chalk this increase up to climate change as waters warm and violent weather becomes the norm.

    Twenty-nine countries have reported cases of cholera already this year — some of which, such as Haiti, Syria, and Lebanon, haven't seen an outbreak in years. Over the past five years, an average of less than 20 countries reported outbreaks per year. Furthermore, the average case fatality rate this year is nearly three times the rate seen during the past five years.  

    This is a preview of Devex CheckUp 
    Sign up to this newsletter for exclusive global health news and insider insights, in your inbox every Thursday.

    “We've seen a dramatic increase in the number of cases of cholera,” UNICEF health specialist Raoul Kamadjeu tells Sara, echoing the words of World Health Organization chief Tedros Adhanom Ghebreyesus, who said cholera was being “turbocharged by climate change.”

    • It’s a water-borne disease, and populations of cholera-causing bacteria increase as water temperatures rise. Floods, monsoons, cyclones, and hurricanes stir up sediment and contaminate water. They also destroy water and sanitation infrastructure — often leeching sewage into the water. When there is drought, people are often left with only sediment-rich, contaminated water.

    • These weather events spur widespread migration. Displacement camps are often crowded with inadequate sanitation — becoming breeding grounds for cholera. And because of the uptick in cases, demand is so high for cholera vaccines that WHO and its partners said there aren’t enough, so it lowered the recommended doses from two to one to broaden access.

    • Cholera is particularly dangerous for malnourished children. "If they get cholera and don't go directly to the health center, they will die in hours," says IFRC’s Alexandra Machado.  

    Read: Cholera thrives in a warming world

    + For more climate change news, check out our Road to COP 27 series. Also, before COP 27, join Devex and a panel of experts to get ahead of the discussions and hear about the key issues to watch. Register now.

    Penny pinching 

    The Financial Intermediary Fund for Pandemic Prevention, Preparedness and Response is underfunded — by a lot, our colleague Shabtai Gold writes. Donors have given just $1.4 billion of the $10.5 billion it needs annually. It's a trust fund that pools public and private money to prevent, prepare for, and respond to future pandemics. While the intention was that countries would allocate new money to this fund, there is a temptation for high-income governments to just move funds around within existing budgets, according to Center for Global Development’s Peter Barker.

    Read: The pandemic readiness fund is short on cash. It's not the only issue. (Pro)

    + Not yet a Devex Pro member? Sign up for a free 15-day trial of Pro to access this story.

    Somalia deteriorating

     “The warning signs of this crisis have been clear for at least the past year, but funds have not come in time for too many.”

    —Awil Abukar Mohamed, senior media and communication officer, Islamic Relief Somalia

    In Somalia’s devastating drought, child mortality has increased significantly, Mohamed writes in an op-ed for Devex. More than 700 children have died in official nutrition centers — but that’s an underestimate, as many deaths are undocumented.

    “In the camps, I met young children so malnourished and weak that they could barely stand. Some had not eaten for days or had survived on a diet of wild fruits that are not usually fit for humans to eat,” Mohamed writes.

    Opinion: Somalia needs the world to wake up now

    ICYMI: Sara visited drought-impacted communities in Mogadishu and Baidoa, Somalia in late August, when the situation was already dire. She also reported on the politics surrounding a famine declaration — and why the world shouldn’t wait for one before pumping in resources.

    Upcoming events

    EGYPT
    COP27 Health Pavilion
    Nov. 6-18

    GERMANY
    15th European Public Health Conference 2022
    Nov. 9-12

    KENYA
    IQVIA Africa Health Summit
    Nov. 16-17

    SOUTH AFRICA
    The Global Health Network Conference
    Nov. 24-25

    See more events

    Getting their ACT-A together

    Last month, we reported the transition plan for Access to COVID-19 Tools Accelerator, or ACT-A, will be out soon. We now know that it is expected to be announced tomorrow. Here are some questions we have in the meantime:

    • “The ACT Accelerator has to change,” WHO’s Dr. Bruce Aylward, who coordinates the work of ACT-A, told our colleague Jenny Lei Ravelo. Aylward said that the initiative also plans to increase procurement and access to treatments. Will there be new structures put in place, and how will funding be organized?

    • Aylward also said that the work of partner organizations, including Gavi, Unitaid, and the Global Fund might change over time. How will this be coordinated across agencies?

    • In a separate interview, Dr. Ayoade Alakija, the WHO special envoy for ACT-A, told us that one of the key weaknesses of the initiative was poor communication that led to inequity. How will the transition plan tackle this?

    • Earlier this month, two-thirds of the respondents of an independent evaluation felt that the ACT-A model should not be replicated — does the new plan address this concern?

    Don’t miss our analysis of ACT-A’s transition plan in tomorrow’s Newswire. Sign up now to receive it.

    Gates way

    $8,589,796

    —

    That’s how much money the Bill & Melinda Gates Foundation gave to the Institut Pasteur de Dakar to fund the technology transfer needed to manufacture measles and rubella vaccines for routine immunization campaigns in low- and middle-income countries.

    The technology transfer will take one year and then production for trials and submission for regulatory approvals will commence, Dr. Joe Fitchett, senior adviser for biotechnology at the institute, tells Sara.

    ICYMI: Senegal nears completion of 'bespoke' vaccine manufacturing facility (Pro)

    Mushrooming problem  

    Your next job?

    Individual Consultant: Geographic Health Information System (GIS) Project
    United Nations Development Programme
    Kiribati/Remote

    See more jobs →

    WHO released its first list of 19 fungi that most threaten human health. Fungal pathogens are becoming more common and resistant to treatment, but there are only four classes of antifungal medicines on the market and a slim pipeline for new ones.  

    What we’re reading

    We may only have a few months to prevent the next pandemic, writes one doctor with experience battling epidemics. [The New York Times]

    Merck says it has located a frozen batch of undisclosed Ebola vaccine, which will be donated for testing in Uganda’s outbreak. [Science]

    Extreme flooding and other climate-related disasters are leading to explosive disease outbreaks. [Scientific American]

    • Funding
    • Global Health
    • Private Sector
    • Trade & Policy
    • Water & Sanitation
    • UNICEF
    Printing articles to share with others is a breach of our terms and conditions and copyright policy. Please use the sharing options on the left side of the article. Devex Pro members may share up to 10 articles per month using the Pro share tool ( ).

    About the authors

    • Sara Jerving

      Sara Jervingsarajerving

      Sara Jerving is a Senior Reporter at Devex, where she covers global health. Her work has appeared in The New York Times, the Los Angeles Times, The Wall Street Journal, VICE News, and Bloomberg News among others. Sara holds a master's degree from Columbia University Graduate School of Journalism where she was a Lorana Sullivan fellow. She was a finalist for One World Media's Digital Media Award in 2021; a finalist for the Livingston Award for Young Journalists in 2018; and she was part of a VICE News Tonight on HBO team that received an Emmy nomination in 2018. She received the Philip Greer Memorial Award from Columbia University Graduate School of Journalism in 2014.
    • Amruta Byatnal

      Amruta Byatnalamrutabyatnal

      Amruta Byatnal is a Senior Editor at Devex where she edits coverage on global development, humanitarian crises and international aid. She writes Devex CheckUp, a weekly newsletter on the latest developments in global health. Previously, she worked for News Deeply in the United States, and The Hindu in India. She is a graduate of Cornell University where she studied international development. She is currently based in New Delhi.

    Search for articles

    Related Stories

    Devex CheckUpDevex CheckUp: There are many global health challenges, but funding is the biggest

    Devex CheckUp: There are many global health challenges, but funding is the biggest

    Devex CheckUpDevex CheckUp: Trump admin proposes sweeping cuts to global health

    Devex CheckUp: Trump admin proposes sweeping cuts to global health

    Devex CheckUpDevex CheckUp: Everything accomplished at the World Health Assembly so far

    Devex CheckUp: Everything accomplished at the World Health Assembly so far

    Devex CheckUpDevex CheckUp: Who will pay to end the AIDS epidemic?

    Devex CheckUp: Who will pay to end the AIDS epidemic?

    Most Read

    • 1
      Laid-off USAID workers struggle to find work as new job cuts approach
    • 2
      Philanthropic initiative launches long-term fund to replace USAID stopgap
    • 3
      Exclusive: A first look at the Trump administration's UNGA priorities
    • 4
      Opinion: Resilient Futures — a world where young people can thrive
    • 5
      Opinion: Women’s voices reveal a maternal medicines access gap
    • News
    • Jobs
    • Funding
    • Talent
    • Events

    Devex is the media platform for the global development community.

    A social enterprise, we connect and inform over 1.3 million development, health, humanitarian, and sustainability professionals through news, business intelligence, and funding & career opportunities so you can do more good for more people. We invite you to join us.

    • About us
    • Membership
    • Newsletters
    • Advertising partnerships
    • Devex Talent Solutions
    • Post a job
    • Careers at Devex
    • Contact us
    © Copyright 2000 - 2025 Devex|User Agreement|Privacy Statement